New cancer clinical trial: Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

Published on: March 07, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Apatinib;   Radiation: SBRT
Sponsors:   Yan Li;   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
http://ift.tt/2FxJ0hl